---
title: Research
description: fume.bio research documentation
navigation: false
---
::card-group
  ::card
  ---
  title: Tirzepatide
  to: /research/peptides/tirzepatide
  ---
  A novel, dual GIP/GLP-1 receptor agonist that significantly improves glycemic control and promotes substantial weight loss in patients with type 2 diabetes.
  ::

  ::card
  ---
  title: Retatrutide
  to: /research/peptides/retatrutide
  ---
  A novel, triple-agonist peptide that targets GIP, GLP-1, and glucagon receptors, offering significant weight loss and metabolic benefits for patients with obesity and type 2 diabetes.
  ::

  ::card
  ---
  title: Cagrilintide
  to: /research/peptides/cagrilintide
  ---
  A novel, long-acting amylin receptor agonist that offers significant weight loss benefits and improved metabolic control for patients with obesity and type 2 diabetes.
  ::
::
